Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Review of the literature
- 1 February 2005
- journal article
- review article
- Published by Elsevier in Autoimmunity Reviews
- Vol. 4 (2) , 111-115
- https://doi.org/10.1016/j.autrev.2004.11.009
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Evidence of transplacental passage of hydroxychloroquine in humansArthritis & Rheumatism, 2002
- Antimalarial agents in pregnancyThe Lancet, 2002
- Ocular toxicity and antenatal exposure to chloroquine or hydroxychloroquine for rheumatic diseasesThe Lancet, 2001
- Hydroxychloroquine and lupus pregnancy: review of a series of 36 cases.Annals of the Rheumatic Diseases, 1996
- The Safety of Antimalarial Drugs in PregnancyDrug Safety, 1996
- A Randomized Study of the Effect of Withdrawing Hydroxychloroquine Sulfate in Systemic Lupus ErythematosusNew England Journal of Medicine, 1991
- Bioavailability of hydroxychloroquine tablets in healthy volunteers.British Journal of Clinical Pharmacology, 1989
- Effects of antiinflammatory and immunosuppressive drugs on pregnancy and fertilitySeminars in Arthritis and Rheumatism, 1988
- Antimalarial drugs and pregnancyThe American Journal of Medicine, 1988
- Ototoxicity of ChloroquineJAMA Otolaryngology–Head & Neck Surgery, 1968